Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Green tea is a beverage made from the leaves of the Camellia sinensis plant that have not been fermented or oxidized like other teas. It contains natural plant compounds called catechins, with epigallocatechin-3-gallate (EGCG) being the most abundant. EGCG is studied for its potential effects on health, including antioxidant and anti-inflammatory properties. Green tea is widely consumed worldwide and is sometimes discussed in cancer care contexts for its possible supportive roles.
In cancer care, green tea and its extracts are sometimes considered for their potential to support nutrition, metabolism, inflammation control, digestion, immune resilience, and tolerance to cancer treatments. Some laboratory and animal studies suggest that EGCG may affect cancer cells differently than normal cells, but these findings have not been confirmed in human clinical trials. Green tea is not an approved cancer treatment, and its role remains experimental or complementary at best.
Patients with cancer often have special health concerns such as immune suppression, risk of bleeding, organ impairment, or drug interactions. Because of this, green tea or its extracts should be used cautiously and only after discussing with the oncology care team.
Patients may encounter green tea or EGCG mentioned in medical records, treatment plans, or discussions about complementary therapies. Some may hear about green tea extracts promoted in alternative or integrative cancer care settings, including products linked to protocols like the Beljanski Extracts, which include green tea blends. These products are not part of standard medical care and lack strong evidence for safety or effectiveness in cancer treatment.
Side effects reported with green tea or its extracts include nausea, heartburn, headache, chest pain, and gastrointestinal symptoms. High doses, especially from supplements, may cause liver toxicity. Absorption of EGCG from oral intake is limited, and large amounts equivalent to many cups of green tea may increase side effects.
Green tea or EGCG may appear in clinical trial descriptions, dietary supplement discussions, nutrition counseling, or integrative medicine notes. It can also be mentioned in research studies exploring cancer prevention or supportive care. If green tea or its extracts are referenced in a patient’s medical record or treatment plan, it is important to ask the care team what it means for that individual’s diagnosis, treatment, and overall health status.
Seeing green tea or EGCG mentioned does not mean it is a proven cancer treatment or that it will improve outcomes. It is not approved by the FDA for cancer treatment or prevention. The presence of green tea in a care plan or record should not be interpreted as a recommendation to use it without professional guidance. It also does not replace standard cancer therapies or monitoring.
Patients and caregivers can ask: How might green tea or EGCG affect my current cancer treatment or medications? Are there any risks or side effects I should watch for? Is it safe for me to use green tea or supplements given my health status? What dose, if any, would be considered safe? How does green tea fit into my overall nutrition and supportive care plan? Should liver function or other tests be monitored if I use green tea extracts?
Because green tea and EGCG appear in many research and complementary care discussions, it is important to understand the context. Look at how it is described—whether as a dietary supplement, part of a clinical trial, or an alternative therapy. Consider the source of the information and whether it relates to your specific cancer type, stage, and treatment. Always discuss any use of green tea products with your oncology team before starting or stopping them.
This information is educational and does not replace medical advice. Green tea and its extracts may interact with cancer treatments or cause side effects, especially in vulnerable patients. The safest approach is to review any interest in green tea with clinicians who know your diagnosis, treatments, medications, and overall health. If green tea or EGCG appears in your medical records or care discussions, ask your care team what it means for you personally. This helps ensure safe, coordinated care tailored to your needs.
Public source information used for this glossary entry includes: